Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HEXO HEXO	$0.71 +2.5%	$0.87	$0.66 ▼ $3.84	$31.24M	1.35	880,508 shs	305,500 shs
HLS HLS Therapeutics	C$4.92 +0.6%	C$4.23	C$3.34 ▼ C$7.12	C$157.05M	1.16	9,973 shs	601 shs
NXS Nexus Gold	C$0.02 +33.3%	C$0.02	C$0.02 ▼ C$0.10	C$837K	0.85	68,853 shs	61,000 shs

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HEXO HEXO	0.00%	0.00%	0.00%	0.00%	-40.83%
HLS HLS Therapeutics	+0.61%	-1.80%	+21.48%	+21.48%	-18.00%
NXS Nexus Gold	0.00%	0.00%	-20.00%	+33.33%	+300.00%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HEXO HEXO	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HLS HLS Therapeutics	0.0452 of 5 stars	1.1	0.0	1.7	0.0	0.4	0.8	0.0
NXS Nexus Gold	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HEXO HEXO	N/A	N/A	N/A	N/A
HLS HLS Therapeutics	2.25	Hold	C$4.58	-7.01% Downside
NXS Nexus Gold	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest HEXO, HLS, NXS, and EOF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/18/2024	HLS HLS Therapeutics	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$6.50 ➝ C$5.00
3/15/2024	HLS HLS Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$4.35 ➝ C$4.15
2/22/2024	HLS HLS Therapeutics	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$5.00 ➝ C$4.35
2/6/2024	HLS HLS Therapeutics	Clarus Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HEXO HEXO	$146.20M	0.21	N/A	N/A	$2.44 per share	0.29
HLS HLS Therapeutics	C$63.07M	2.49	C$0.32 per share	15.22	C$3.06 per share	1.61
NXS Nexus Gold	N/A	N/A	C$0.00 per share	10.00	C($0.01) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HEXO HEXO	-$845.90M	-$5.21	N/A	N/A	N/A	-235.33%	-74.04%	-32.51%	N/A
HLS HLS Therapeutics	-C$27.53M	-C$1.16	N/A	∞	N/A	-43.65%	-24.69%	-2.87%	5/9/2024 (Estimated)
NXS Nexus Gold	-C$1.92M	-C$0.06	N/A	∞	N/A	N/A	-1,307.50%	-53.77%	5/29/2024 (Estimated)

Latest HEXO, HLS, NXS, and EOF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/14/2024	Q4 2023	HLS HLS Therapeutics	-C$0.13	-C$0.18	-C$0.05	-C$0.13	C$21.83 million	C$21.60 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HEXO HEXO	N/A	N/A	N/A	N/A	N/A
HLS HLS Therapeutics	C$0.20	4.07%	N/A	N/A	N/A
NXS Nexus Gold	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HEXO HEXO	0.01	0.41	0.24
HLS HLS Therapeutics	89.69	1.65	1.01
NXS Nexus Gold	14,120.33	0.05	0.38

Ownership

Institutional Ownership

Company	Institutional Ownership
HEXO HEXO	7.78%
HLS HLS Therapeutics	59.62%
NXS Nexus Gold	N/A

Insider Ownership

Company	Insider Ownership
HEXO HEXO	4.69%
HLS HLS Therapeutics	0.49%
NXS Nexus Gold	0.51%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
HEXO HEXO	1,277	44.00 million	41.93 million	Optionable
HLS HLS Therapeutics	91	31.92 million	N/A	Not Optionable
NXS Nexus Gold	N/A	41.87 million	N/A	Not Optionable

HEXO, HLS, NXS, and EOF Headlines

Source	Headline
	Nexus Gold Announces Private Placement goldseiten.de - April 12 at 5:26 PM
	Nexus Gold Updates Dakouli 2 Gold Concession, Burkina Faso, West Africa stockhouse.com - April 12 at 12:25 PM
	Nexus War Civilization Codes (February 2024) twinfinite.net - March 29 at 9:39 PM
	'Stellaris Nexus' Is Now Called 'Nexus 5X' And Gets April Release Date - Trailer worthplaying.com - March 21 at 7:20 PM
	Web3 Gaming Company Saltwater Raises $5.5M Seed Funding markets.businessinsider.com - February 1 at 10:47 AM
	Nexus Gold Provides Update on Public Listing of Nexus Metals goldseiten.de - January 30 at 5:12 PM
	Nexus G1 Blackmagic box camera project creates controversy redsharknews.com - January 12 at 7:15 AM
	The Nexus G1. A Box Camera Mod Using the Blackmagic Design Pocket 6K G1 newsshooter.com - January 6 at 6:40 PM
	Excision Adds Nexus Tour Dates to Kia Forum — Here’s How To Get Presale Code Tickets grimygoods.com - December 13 at 7:37 PM
	Nexus Gold Corp Class A morningstar.com - December 7 at 8:17 PM
	Nexus Gold and Belgravia Hartford Jointly Announce Revised Debt Settlement Transaction finance.yahoo.com - November 22 at 6:31 PM
	Closing Bell: Nexus Gold Corp down on Monday (NXS) theglobeandmail.com - November 15 at 7:27 PM
	All You Need To Know About ‘Nexus One’ Mobile App Launched By Navi Mumbai's Nexus Seawoods Mall msn.com - November 6 at 8:50 AM
	How Does Nexus Blitz Work In LOL? msn.com - October 30 at 3:50 AM
	Closing Bell: Nexus Gold Corp down on Thursday (NXS) theglobeandmail.com - October 20 at 8:46 PM
	Closing Bell: Nexus Gold Corp up on Friday (NXS) theglobeandmail.com - October 14 at 9:59 AM
	Closing Bell: Nexus Gold Corp up on Monday (NXS) theglobeandmail.com - October 3 at 1:24 AM
	BELGRAVIA HARTFORD Announces 13% Ownership in Nexus Gold and a 13% Ownership for Pennsylvania Hawthorne finance.yahoo.com - August 30 at 7:01 AM
	Nexus Gold Announces Debt Settlement goldseiten.de - August 28 at 8:26 PM
	Closing Bell: Nexus Gold Corp flat on Tuesday (NXS) theglobeandmail.com - August 3 at 6:32 PM
	Closing Bell: Nexus Gold Corp up on Thursday (NXS) theglobeandmail.com - August 3 at 6:32 PM
	Closing Bell: Nexus Gold Corp flat on Friday (NXS) theglobeandmail.com - July 15 at 9:06 AM
	Nexus Gold Provides Update on Private Placement goldseiten.de - June 30 at 6:50 PM
	Nexus Gold Options Fofora Gold Project, Hounde Greenstone Belt, Burkina Faso juniorminingnetwork.com - June 7 at 3:32 PM

New MarketBeat Followers Over Time

Company Descriptions

HEXO

NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

HLS Therapeutics

TSE:HLS

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.

Nexus Gold

CVE:NXS

Nexus Gold Corp. engages in the exploration and evaluation of mineral properties in West Africa and Canada. The company explores for gold, silver, manganese, bauxite, copper, nickel, lead, zinc, and limestone/marble deposits. Its flagship property is the Bouboulou project located in Burkina Faso, West Africa. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial